palbociclib,trastuzumab,pembrolizumab
pfizer,roche,merck
['pearl', 'lung']
pleased to present these results at #asco2022 for toga and the pearl team - no clear qol or survival benefit with routine early referral of all pts with advanced lung cancer to palliative care in australia. important given limited palliative care resources 
Medical Oncologist, Gynaecological and Lung Cancers, Carcinoma of Unknown Primary. Views are entirely my own